Improving predictability and transparency in DEA and FDA regulation : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, second session, April 7, 2014.

Improving predictability and transparency in DEA and FDA regulation : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, second session, April 7, 2014.

Show other versions (1)
Saved in:
Bibliographic Details
Corporate Author: United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Health (Author)
Format: Government Document Book
Language:English
Published: Washington : U.S. Government Publishing Office, 2015.
Subjects:
Drugs of abuse > Law and legislation > United States.
Drugs > Law and legislation > United States.
Drug approval > United States.
Drug accessibility > United States.
Drug accessibility.
Drug approval.
Drugs > Law and legislation.
Drugs of abuse > Law and legislation.
United States.
Legislative hearings.
Description
Item Description:Shipping list number: 2015-0330-P.
"Serial Number 113-147."
Physical Description:iv, 217 pages ; 24 cm.
Bibliography:Includes bibliographical references.

Similar Items